Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000440404 | SCV000521048 | likely benign | not specified | 2016-03-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000440404 | SCV000703960 | likely benign | not specified | 2016-12-22 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV000664148 | SCV000787600 | likely benign | Monogenic diabetes | 2019-02-15 | criteria provided, single submitter | research | ACMG criteria: PP3 (7 predictors), BP4 (2 predictors), BS2 (6 controls and 11 cases in T2DM and 2 homozygotes in ExAC) NOTE: GeneDx calls likely benign=Likely Benign |
Institute of Human Genetics, |
RCV001127842 | SCV000926180 | uncertain significance | Renal cysts and diabetes syndrome | 2019-07-06 | criteria provided, single submitter | literature only | |
Illumina Laboratory Services, |
RCV001127842 | SCV001287192 | benign | Renal cysts and diabetes syndrome | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV002062432 | SCV002405253 | benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002062432 | SCV004144498 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | HNF1B: BS2 |
Ambry Genetics | RCV004022349 | SCV005035557 | likely benign | Maturity onset diabetes mellitus in young | 2023-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Gastroenterology and Hepatology, |
RCV001844831 | SCV001877062 | likely benign | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research | |
Genetic Services Laboratory, |
RCV000440404 | SCV003839585 | likely benign | not specified | 2022-09-07 | no assertion criteria provided | clinical testing |